I'm sorry you feel that way. I am actually a shareholder so I call it as I see fit.
You are entitled to think whatever you want, as am I. If I don't agree with you then there is no need for you to take offence and start with the name calling. Tsk tsk.
BTW, what would you like me to analyse numerically? Not a lot of data to work with on R&D stocks so pulling the balance sheet to pieces really achieves nothing at this juncture.
But if you insist on knowing what I think, the intangible asset figure of 2.2m at 31 December 2017 is very realistic and they are not loading development costs with items I would consider to be expenses.
SAS Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
